Evaluating Functional Equivalency as a Lyophilization Cycle Transfer Tool - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Evaluating Functional Equivalency as a Lyophilization Cycle Transfer Tool
The authors describe a comprehensive methodology for establishing functional equivalence among various lyophilizers.


Pharmaceutical Technology
Volume 33, Issue 9, pp. 54-70


Figure 3: Lyophilizer performance (partial load): chamber pressure, shelf temperature, mean product temperature, and condenser temperature for FD-104 (B420FT) and FD-105 (C220FT). (FIGURE IS COURTESY OF THE AUTHOR)
Tables IV and V show that even during this early period of drying, the rates of drying among various units were quite close to each other (i.e., 1.79% and 3.21%) in fully loaded and partially loaded conditions, respectively. These results were irrespective of the locations of the trays within the units. The differences in the drying rates among vials located at corresponding locations were slightly more variable but within 10% of each other.


Table VI: Comparison of lyophilization process parameters (partial load): shelf temperature, condenser temperature, and chamber pressure in B420FT and C220FT.
Comparison of process parameters during cycles. The equipment parameter data from the drying rate studies conducted under partial- and full-load conditions were analyzed for this comparison. Under full-load conditions (i.e., 210 trays), a large amount of solution (~800 kg) is subjected to the lyophilization process. Under such a large load, the system capabilities are fully challenged. In spite of such a full-load condition, the flawless execution of the lyophilization cycles while maintaining all the independent and dependent parameters within the narrow limits clearly confirms that these units are capable of performing according to the set parameters and that the profiles generated are comparable with each other.


Table VII: Comparison of lyophilization process parameters (full load): shelf temperature, condenser temperature, and chamber pressure in A420FT, B420FT, and C220FT.
The temperature-pressure rate profiles reflect close agreement of the lyophilization parameters during the entire run (see Figures 2, 3). (Note: lyophilizer units A420FT, B420FT, and C220FT are referred to as FD-103, FD-104, FD-105, respectively) The independent parameters (i.e., the shelf temperature, chamber pressure, and the condenser temperature) were within the overlapping range throughout the course of the cycle in all three lyophilizers (see Tables VI and VII). Moreover, the mean product temperatures were within the overlapping range throughout the course of the cycle in all three lyophilizers (see Figures 2 and 3). These parameters are the actual indicators of equipment performance under stress conditions and their close agreement with the programmed recipe confirms excellent capability of these units.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
18%
To all process for new products only
13%
To select process for new products only
22%
To select processes for both new and legacy products
22%
Do not use QbD
24%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here